LTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
more
Stories from Andernach
- Language:
- Media:
- Period:
- Period:Total
LTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreLTS Lohmann Therapie-Systeme AG
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
moreLTS Lohmann Therapie-Systeme AG
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array Patches (“MAP”) announces the signing of the ...
moreLTS Lohmann Therapie-Systeme AG
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.
Andernach, Germany (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”) announces the closing of the acquisition of Tapemark Inc. (“Tapemark”) located in St. Paul, MN, USA. This acquisition combines Tapemark, a world-class CDMO specialized in transdermal drug delivery systems and oral thin films as well as unit dose semi-solid drug and iontophoresis products with ...
moreTinplate packaging with 90.4% recycling rate
more
1